Drugs / Amoxicillin/clavulanate potassium
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01110421 Background | Dec 2010 → Mar 2012 | bacterial pneumonia, nosocomial infection | Janssen Research & Development, LLC | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amoxicillin/clavulanate potassium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01110421 ↗ |
| Route | Oral | “Route=oral (by mouth)” NCT01110421 ↗ |